News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Mario Balsa: POLCA-GB at ASCO25
Mario Balsa/X
Jun 2, 2025, 09:10

Mario Balsa: POLCA-GB at ASCO25

Mario Balsa, Medical Oncology resident at ICO, posted on X:

“POLCA-GB at ASCO25
Preop chemoradiation (CRT) doubles median OS vs chemo alone in locally advanced GB: mOS: 21.8 vs 10.1 mo (HR 0.53, p=0.003)
  • 5-yr OS: 28.9% vs 17%
  • EFS, PFS and ORR all improved
Preop CRT: ready for primetime in GBC? From signal to standard.”
Mario Balsa: POLCA-GB at ASCO25

More posts featuring ASCO25.

ASCO25 cancer Mario Balsa OncoDaily Oncology POLCA-GB
Special Coverage
Insight
Jul 16, 2025, 18:12
Daniel Flora: A Paradigm Shift in Cancer Care - Immunotherapy Before Surgery Delivers Long-Term Survival
Insight
Jul 16, 2025, 17:55
Hung Trinh: TKIs Show Clinical Promise in Recurrent Ewing’s Sarcoma
Blog
Jul 16, 2025, 17:38
How to Make Cancer Terms Easier to Understand?
Insight
Jul 16, 2025, 17:37
Partha Basu: Setting the Stage for the Third European Screening Report
Science
Jul 16, 2025, 17:16
Hagop Kantarjian: What is the Recommended Phase 2 Dose of SQ Blinatumomab in R-R ALL
Insight
Jul 16, 2025, 17:13
From U.S. Newsrooms to Crossing Military Checkpoints in Palestine for Children - CancerWorld
Blog
Jul 16, 2025, 17:04
Sachin Jain: Stay True to Yourself
Blog
Jul 16, 2025, 16:51
Uma Borate: Fantastic Start to the Pan Pacific Leukemia Conference 2025
Insight
Jul 16, 2025, 16:34
ASCO 2025 For Trainees And Residents
Insight
Jul 16, 2025, 16:28
Devika Das: UF Interns Completed Their First Block on the Inpatient Oncology Service
Blog
Jul 16, 2025, 16:18
What Causes Multiple Myeloma? - International Myeloma Foundation
Opinion
Jul 16, 2025, 16:06
How Geriatric Oncology is Reshaping Care Models Worldwide - SIOG